South Korea-based ADEL said late on Monday that it has entered a $1.04 billion partnership with French drugmaker Sanofi to ...

Music motivates and inspires and is a powerful and nonthreatening medium and therefore, people with Alzheimer’s react ...

Charlie Quirke's trek, which finished at the family home in Buckinghamshire, included "iconic locations" from his mother's ...

Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their failure, underscore a shift to ...

Despite reported slowing of progression, regulators said the evidence on the novel oral agent blarcamesine did not support a ...

Regardless of the experiences and material things that money can offer, at the end of the day, kids "just want your time," ...

In the United States, 7.2 million people are currently living with Alzheimer’s, with over 5 million of them being over the ...

UVA researchers found even minor trauma can disrupt the brain’s cleanup system, allowing harmful proteins to build up over ...

A shared molecular signature of Alzheimer’s appears across populations once studied in isolation. Alzheimer's disease (AD) ...

We are approaching the end of 2025, a year of remarkable breakthroughs in medicine, technology, and lifestyle. From AI ...

Conventional Alzheimer’s therapies often target only a single pathological feature, such as amyloid aggregation or oxidative ...

In the last few years, progress has been made in the fight against Alzheimer's disease with a class of therapies called ...